Concepedia

Jonathan C. Lansing

JC

Statistics

Publications

14

Citations

2.2K

H-Index

14

Active since

1998

Affiliations

Massachusetts Institute of Technology(Current)

Momenta Pharmaceuticals (United States)

Brandeis University

Scripps Research Institute

Harvard University

Jonathan C. Lansing is an author at Massachusetts Institute of Technology specializing in biochemistry, biophysics, and life sciences.

ORCID

Publications per year

1998–2018

14

Publications

14

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

Marco Guerrini, Daniela Beccati, Zachary Shriver et al. · Nature Biotechnology · 2008 · 617 citations

, , +7

Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System

Takashi Kishimoto, Karthik Viswanathan, Tanmoy Ganguly et al. · New England Journal of Medicine · 2008 · 616 citations · Full text

, , +12

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Nathaniel Washburn, Inessa Schwab, Daniel Ortiz et al. · Proceedings of the National Academy of Sciences · 2015 · 226 citations · Full text

, , +17

Defining the role of active-site loop fluctuations in dihydrofolate reductase catalysis

Dan McElheny, Jason R. Schnell, Jonathan C. Lansing et al. · Proceedings of the National Academy of Sciences · 2005 · 164 citations · Full text

, , +17

High-Frequency Dynamic Nuclear Polarization in MAS Spectra of Membrane and Soluble Proteins

Mélanie Rosay, Jonathan C. Lansing, Kristin Coffman Haddad et al. · Journal of the American Chemical Society · 2003 · 121 citations

, , +15

1–5 of 14